Concurrent Chemoradiation in Anal Cancer Patients Delivered with Bone Marrow-Sparing IMRT: Final Results of a Prospective Phase II Trial

We investigated the role of the selective avoidance of haematopoietically active pelvic bone marrow (BM), with a targeted intensity-modulated radiotherapy (IMRT) approach, to reduce acute hematologic toxicity (HT) in anal cancer patients undergoing concurrent chemo-radiation. We designed a one-armed...

Descripción completa

Detalles Bibliográficos
Autores principales: Arcadipane, Francesca, Silvetti, Patrick, Olivero, Francesco, Gastino, Alessio, Carlevato, Roberta, Chiovatero, Ilaria, Spinelli, Lavinia, Mistrangelo, Massimiliano, Cassoni, Paola, Ritorto, Giuliana, Gallio, Elena, Lesca, Adriana, Faletti, Riccardo, Giglioli, Francesca Romana, Fiandra, Christian, Ricardi, Umberto, Franco, Pierfrancesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157357/
https://www.ncbi.nlm.nih.gov/pubmed/34069862
http://dx.doi.org/10.3390/jpm11050427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8157357/
https://www.ncbi.nlm.nih.gov/pubmed/34069862
http://dx.doi.org/10.3390/jpm11050427

Ejemplares similares